ACECLOFENAC LOADED SOLID LIPID NANOPARTICLES: OPTIMIZATION, IN VITRO AND EX-VIVO EVALUATION
Objective: Rheumatoid arthritis is treated with aceclofenac as the first line of treatment. Aceclofenac is a BCS-II drug, when taken orally, causes first-pass metabolism and is partially water-insoluble causing some gastrointestinal (GI) issues. Objective of the work was preparation and evaluation o...
Gespeichert in:
Veröffentlicht in: | International journal of applied pharmaceutics 2023-07, p.184-190 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!